Abbisko taps Hong Kong IPO market for $225m

Biopharmaceutical firm Abbisko kicked off bookbuilding for its Hong Kong IPO on Thursday, aiming to raise HK$1.75bn ($225.2m). The Shanghai-based company specialises in the discovery and development ... ( read original story ...)

Renewed Support Called For China Stock Market

The China stock market has alternated between positive and negative finishes through the last four trading days since the end of the three-day losing streak in which it had climbed more than 35 points ... ( read original story ...)